What You Should Know: - Ibex Medical Analytics, the pioneer in AI-based cancer diagnostics, today announced that it has signed a deal with Roche, the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology,
Read More
Prenosis, Roche Partner to Combat Hospital Sepsis Using Precision Diagnostics
What You Should Know: - Prenosis Inc., a precision diagnostics company transforming clinical diagnosis with artificial intelligence, announced today the expansion of an existing partnership with Roche Diagnostics that will total close to $6 million to improve and expedite the clinical recognition of sepsis. - Building upon the collaboration that the companies started together in 2020, Prenosis will significantly expand its core NOSIS™ dataset, and the two companies will work together
Read More
Innovaccer, Roche Partner to Develop Clinical Decision Support Solutions
What You Should Know: - Innovaccer Inc. the Health Cloud company, announced it has entered into a three-year collaboration with Roche to partner in the development of innovative clinical decision support solutions on the InnovaccerⓇ Health Cloud for the U.S. market. - As part of the strategic collaboration, the Innovaccer Health Cloud and its core Data Activation Platform will be used to integrate disparate data from EHRs, labs, claims, pharmacy—virtually any healthcare data
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know: - The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million. - Digital diabetes solutions have disrupted the
Read More
Babyscripts Forms Commercial Partnership with Roche to Develop RPM Programs for Pregnancy
What You Should Know: - Babyscripts today announced a commercial partnership with
Roche Diagnostics, a division of the world’s largest biotech company and a
global pioneer in pharmaceuticals and diagnostics. - Roche will partner with Babyscripts on the
development of Babyscripts’ remote patient monitoring (RPM) programs to
leverage groundbreaking data science through the next generation of RPM in
pregnancy. Babyscripts, a
Washington D.C.-based
Read More
Corindus Vascular Robotics CEO Departure, UPMC Enterprises’ New President, Nordic Consulting’s New CIO, Other Health IT Hires
Mark Toland, CEO of Corindus Vascular Robotics (acquired by Siemens for $1.1B last year), has announced his departure and will be joining BioStar Capital, a health-tech venture capital group focused on cardiovascular and orthopedic medical devices. As a partner and entrepreneur in residence, Mark will help to identify and develop innovative companies leveraging AI, deep learning, robotics, and other transformative technologies that address a wide range of unmet needs. The BioStar team has
Read More
Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments
Evidation’s Board of Directors has appointed Christine Lemke as Co-CEO alongside Executive Chair Deborah Kilpatrick. Greenway Health appoints Pratap Sarker as President to oversee all commercial and customer-focused functions including sales, marketing, and customer success. He will also work closely with Greenway’s clearinghouse, revenue cycle and IT teams to ensure the delivery of quality solutions that are critically needed to support practices’ business continuity, as well as their
Read More
FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes
What You Should Know: - Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system. - The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
2020 MedTech Breakthrough Award Winners Announced
What You Should Know: - MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today. - The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services. MedTech
Breakthrough, a market intelligence organization that recognizes
Read More
